These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 4971892)
1. Protection by vaccination against Pseudomonas infection after thermal injury. Markley K; Smallman E J Bacteriol; 1968 Oct; 96(4):867-74. PubMed ID: 4971892 [TBL] [Abstract][Full Text] [Related]
2. Active and passive immunization with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model. Lieberman MM; Walker HL; Ayala E; Chapa I J Surg Res; 1986 Feb; 40(2):138-44. PubMed ID: 3080639 [TBL] [Abstract][Full Text] [Related]
3. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers]. Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666 [TBL] [Abstract][Full Text] [Related]
4. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice]. Grochowski J; Bilinska M; Stankiewicz D; Arkusiewicz E Pol Przegl Chir; 1979 Jun; 51(6):623-7. PubMed ID: 116210 [No Abstract] [Full Text] [Related]
5. Early protection by vaccines in burns. Jones RJ Br J Exp Pathol; 1971 Feb; 52(1):100-9. PubMed ID: 4993954 [TBL] [Abstract][Full Text] [Related]
6. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients]. Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103 [No Abstract] [Full Text] [Related]
7. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection. Montie TC; Drake D; Sellin H; Slater O; Edmonds S Antibiot Chemother (1971); 1987; 39():233-48. PubMed ID: 3118785 [No Abstract] [Full Text] [Related]
8. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns]. Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556 [No Abstract] [Full Text] [Related]
9. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients. Roe EA; Jones RJ Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970 [TBL] [Abstract][Full Text] [Related]
10. Immunological control of pseudomonas infection in burns. R I Med J; 1972 Mar; 55(3):88. PubMed ID: 4622683 [No Abstract] [Full Text] [Related]
11. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland]. Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869 [No Abstract] [Full Text] [Related]
12. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns. Jones RJ; Lowbury EJ Br J Exp Pathol; 1972 Dec; 53(6):659-64. PubMed ID: 4630411 [TBL] [Abstract][Full Text] [Related]
13. Low mortality in burned patients in a Pseudomonas vaccine trial. Jones RJ; Roe EA; Gupta JL Lancet; 1978 Aug; 2(8086):401-3. PubMed ID: 79764 [TBL] [Abstract][Full Text] [Related]
14. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients. Jones RJ; Roe EA; Gupta JL Lancet; 1980 Dec; 2(8207):1263-5. PubMed ID: 6108445 [TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection. Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581 [TBL] [Abstract][Full Text] [Related]
16. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides. Cryz SJ; Meadow PM; Fürer E; Germanier R Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605 [TBL] [Abstract][Full Text] [Related]
17. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?]. Zellner PR; Zwissler O; Metzger E Chirurg; 1975 Oct; 46(10):462-66. PubMed ID: 815075 [TBL] [Abstract][Full Text] [Related]
18. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection. Okada K; Kawaharajo K; Kasai T; Homma JY Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131 [TBL] [Abstract][Full Text] [Related]
19. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine. Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594 [No Abstract] [Full Text] [Related]
20. Prevention of invasive pseudomonas infection in burns with a new vaccine. Alexander JW; Fisher MW; MacMillan BG; Altemeier WA Arch Surg; 1969 Aug; 99(2):249-56. PubMed ID: 4978523 [No Abstract] [Full Text] [Related] [Next] [New Search]